The Indian automotive sector witnessed robust demand in September 2025, boosted by the recent GST 2.0 reforms and the onset of the festive season. Passenger vehicles, utility vehicles, and commercial vehicles all saw notable upticks, with early Navratri sales...
Synopsis: One of India’s largest car manufacturer, Tata Motors, is splitting its commercial vehicle division into TMLCV, with shareholders receiving one new share per Tata Motors share on Oct 14, 2025. Tata Motors Limited will begin trading without its commercial...
Synopsis: Sun Pharmaceutical Industries Limited is in focus after Citi has assigned a new target price with a buy rating with an upside of more than 34%. Citi, one of the leading global brokerage firms, has set a new target price for a Pharma stock, reflecting its...
Synopsis: Airtel’s leap into ADAS and precision tech could redefine growth, driving innovation across mobility, logistics, tolling, and agriculture. A telecom giant is making waves beyond traditional connectivity as it explores precision technology and advanced...
The shares of a Large-Cap company, specializing in the financing of rolling stock (locomotives, coaches, wagons) and railway infrastructure through leasing and lending activities, are in focus upon signing the term loan agreement to finance the thermal power and...
Shares of a leading defence and aerospace firm rose 1.4% after securing a ₹1,092 crore order for network upgrades, tank systems, and related equipment. Strong order book, revenue growth, improved margins, and strategic product mix indicate robust near-term growth and...
Synopsis: On September 29, 2025, two stocks including Hero MotoCorp Limited and IndusInd Bank Limited were in focus after BNP Paribas Financial Markets acquired stake. The two stocks below saw significant price movements on Tuesday, following a bulk deal on September...
Synopsis: Vodafone Idea is in focus after brokerage has cited that the company can experience another upside of 19%; however, CITI has cited that this play will be a high-risk buy for investors, as both the government and the Supreme Court are looking to ease...
Synopsis: Shares gained modestly after the board cleared two projects worth ₹706 crore for VOIP systems and disaster preparedness. Despite steady revenue, profit slipped slightly, while rising capex, strong project pipeline, and expanding consultancy orders highlight...
Synopsis: US tariffs put Sun Pharma in focus, but proactive measures and a diversified manufacturing strategy may help mitigate potential risks. The recent US decision to impose tariffs on imported patented drugs has raised concerns over the impact on Indian...
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
